Overview
Singer Finance provides lending, leasing, deposit-taking and vehicle finance through branches and digital channels. The central operating change is continued expansion in lending income and profit, while the completed rights issue has added capital for lending and capital adequacy.
Price performance
At LKR 39.90 on 28 October 2026, the share had fallen 17.7% over three months against a 5.9% decline in the ASPI. It sits only 4.0% above its 52-week low, recording a much weaker recent path than the broad market.
Trading has become busier than its own recent norm while 60-day volatility is below the company's one-year norm. The three-year record is four falls of 15% or more, the deepest 51%, which has not yet recovered. Liquidity is limited: a LKR 1 million order is more than everything that trades on a typical day, at 133% of median daily turnover.
Valuation
At 5.94 times earnings, the share costs LKR 5.94 for every LKR 1 of trailing profit. Its 1.08 times P/B means paying LKR 1.08 for each LKR 1 of net assets; the latest audited ROE of 16.3% helps explain a price modestly above book value.
Sector rankings place P/E near the middle, P/B above the middle and the 2.5% dividend yield in the lower quartile. The share is cheaper than 64% of days since January 2019 on P/E, while the dividend record is uneven and the latest distribution was an interim payment. A buyer at this price relies on the latest quarter for 25.3% of trailing EPS; its lower margin would change the P/E only from 5.9 to 5.7 times.
News and sentiment
Coverage was unusually quiet in the past 30 days, with no company articles against a normal monthly baseline of 1.8. Across 90 days there were nine material articles, comprising three positive and six neutral items.
The 2026 rights issue became ex-rights on 16 October. The structured terms offered shares at LKR 39.20, a 5.8% discount to the pre-ex market price; holders who did not take up their entitlement were diluted, while the company received new capital for capital adequacy and lending. Board and committee changes, including Jonathan Alles becoming chairman, were also reported during September.
Financials
September-quarter revenue reached LKR 2.8 billion, up 38.4% year-on-year, while net profit rose 15.9% to LKR 464 million. Profit therefore grew more slowly than income, indicating that the additional lending revenue converted less efficiently into earnings than a year earlier.
Gross margin is unavailable for both comparison periods. Operating margin narrowed from 45.0% to 38.6%, while net margin fell from 19.7% to 16.5%; both were middling against comparable September quarters, ranking third of seven and fourth of seven respectively. The LKR 620 million gap between operating and net profit was wider than LKR 514 million a year earlier, showing that costs below operating profit absorbed more of the improvement.
Equity increased from LKR 6.8 billion to LKR 10.3 billion. The latest balance sheet and today's share count both use 277.9 million shares, against 202.1 million a year earlier, so per-share comparisons across the rights issue are mechanically affected even though absolute profit increased.
Risks
The main risk is balance-sheet leverage inherent in the lender model: total liabilities were 9.04 times equity at March 2026, up from 8.36 times a year earlier. That leaves profitability and capital resilience more sensitive to funding costs, deposit flows and credit outcomes than the headline profit growth alone suggests.
The sector backdrop is less settled, with selected government-bond yields rising and domestic dollar bond bids rejected at rates judged too high. This is not company-specific news, but it raises the importance of funding discipline as Singer Finance expands lending. The latest quarter also showed a lower operating and net margin, so revenue growth has not fully protected profitability.
Outlook
As at 28 October 2026, the next scheduled event is the December 2026 interim-quarter filing, expected between 5 and 14 February 2027. It will be the first scheduled results period to show the post-rights balance sheet and whether the enlarged capital base is translating into lending income without further margin pressure.
The supplied data does not quantify loan quality or capital adequacy ratios. The next filing will therefore clarify earnings and balance-sheet scale, but not fully resolve credit-risk exposure from the figures currently available.